project id: TCGA-LIHC; case submitter id: TCGA-5R-AAAM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.93; rna integrity number: 9.2; age at index: 65; days to birth: -24020; days to death: 46; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1948; year of death: 2013; age at diagnosis: 24020; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 35; days to sample procurement: 0; initial weight: 730.0; portion submitter id: TCGA-5R-AAAM-01A-12; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;